3002.12.00.10 - Human blood plasma 🖩
Details
| Field | Value |
|---|---|
| Unit of Quantity | kg |
| General Rate of Duty (Column 1 - General) | Free |
| Special Rate of Duty (Column 1 - Special) | N/A |
| Column 2 Rate of Duty | Free |
| Quota Quantity | N/A |
| Additional Duties | N/A |
Overview
This HTS category, 3002.12.00.10, specifically encompasses human blood plasma. This includes the liquid component of blood that remains after blood cells have been removed, utilized for various therapeutic, prophylactic, or diagnostic purposes. It is a foundational product derived directly from human blood for medicinal and scientific applications.
Distinguishing this category from its siblings, 3002.12.00.10 is distinct from normal human blood sera (3002.12.00.20), human immune blood sera (3002.12.00.30), and Fetal Bovine Serum (3002.12.00.40). While all fall under the broader heading of blood fractions and immunological products, human blood plasma refers to the unprocessed liquid matrix, whereas sera contain specific antibodies or other immunological components derived from plasma or serum. Fetal Bovine Serum is also a distinct product originating from bovine sources.
As this node represents a leaf node within the HTS, there are no further subcategories. Classification under 3002.12.00.10 therefore requires careful consideration of whether the product is indeed human blood plasma. Documentation confirming the source (human), the preparation process (separation of cellular components), and its intended use (therapeutic, prophylactic, or diagnostic) is critical for accurate classification.